Neurogenesis in Clinical Practice
Recent discoveries linking neurogenesis to central nervous system disease have presented new opportunities for addressing the unmet medical needs of millions afflicted by brain-related illness. BrainCells Inc. is translating the science of neurogenesis into clinical practice with a technology platform built on this pioneering research. BrainCells is using the platform to build a pipeline of clinical stage programs and to help its partners optimize their own CNS development portfolios. See what’s new »
The process by which pre-existing stem cells in the adult human brain produce new brain tissue, including neurons.
The Science
In recent years, neurogenesis has emerged as a fundamental process underlying CNS physiology and disease.
Technology Platform
BrainCells’ platform combines in vitro and in vivo neurogenesis assays to give a complete fingerprint of a compound’s neurogenic profile.
Product Pipeline
Several development candidates derived from BrainCells’ technology platform have entered the clinic.